Related Experiment Videos
Mechanistic considerations in chemopreventive drug development
G J Kelloff1, C W Boone, V E Steele
1Chemoprevention Branch, Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), Bethesda, MD 20892, USA.
Journal of Cellular Biochemistry. Supplement
|January 1, 1994
Summary
This study explores chemopreventive mechanisms for drug discovery, detailing agents that block carcinogens, act as antioxidants, and inhibit proliferation. Understanding these pathways is crucial for developing effective cancer prevention strategies.
Area of Science:
- Oncology
- Pharmacology
- Drug Discovery
Background:
- Chemoprevention offers a strategy to prevent cancer development or recurrence.
- Identifying and understanding the mechanisms of action for chemopreventive agents is essential for drug discovery.
- Existing research highlights diverse mechanisms, including carcinogen blocking, antioxidant activity, and antiproliferative effects.
Purpose of the Study:
- To provide a comprehensive overview of potential chemopreventive mechanisms.
- To establish the conceptual groundwork for chemopreventive drug discovery.
- To guide structure-activity and mechanistic studies for identifying and evaluating new chemopreventive agents.
Main Methods:
- Review and categorization of known chemopreventive activities based on their mechanisms.
- Examples of promising agents are provided for each mechanism.
- Discussion of drug development approaches, including pharmacological activity profiling and structure-activity relationship studies.
Main Results:
- Chemopreventive mechanisms encompass carcinogen blocking (e.g., inhibiting uptake, activation, or DNA binding; enhancing detoxification and DNA repair).
- Antioxidant activities include scavenging reactive species and inhibiting arachidonic acid metabolism.
- Antiproliferation/antiprogression activities involve modulating signal transduction, hormonal activity, oncogene expression, polyamine metabolism, differentiation, immune response, and apoptosis, among others.
Conclusions:
- A systematic approach to chemopreventive drug development requires continued research into mechanisms of action.
- Thoughtful application of mechanistic understanding is key to designing and discovering new chemopreventive agents.
- Pharmacological profiling, structure-activity studies, and mechanism-based assays with biomarkers are vital for evaluating efficacy and optimizing agents.